Skip Navigation

Cardiovascular Research 2004 63(1):168-175; doi:10.1016/j.cardiores.2004.03.020
© 2004 by European Society of Cardiology
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Conklin, B. S
Right arrow Articles by Chen, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Conklin, B. S
Right arrow Articles by Chen, C.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Copyright © 2004, European Society of Cardiology

HIV protease inhibitor ritonavir decreases endothelium-dependent vasorelaxation and increases superoxide in porcine arteries

Brian S Conklin1, Weiping Fu, Peter H Lin, Alan B Lumsden, Qizhi Yao and Changyi Chen*

Michael E. DeBakey Department of Surgery, Division of Vascular Surgery and Endovascular Therapy, Molecular Surgeon Research Center, Baylor College of Medicine, One Baylor Plaza, Mail Stop NAB 2010, Houston, TX 77030, USA

*Corresponding author. Tel.: +1-713-798-4401; fax: +1-713-798-6633. Email address: jchen{at}bcm.tmc.edu

Objective: Although HIV Protease inhibitors significantly reduce the viral load, they are associated with increased risk of cardiovascular disease. The aim of this study was to investigate the effects of HIV protease inhibitor ritonavir on vascular endothelial cell function. Methods: Porcine carotid arteries were perfusion-cultured for 24 h as controls or with 15 µM of ritonavir. Vessels were precontracted with norepinephrine followed by endothelium-dependent vasorelaxation with acetylcholine. Rings of vessels were cultured as controls or with ritonavir for 24 h and basal and NADPH-stimulated superoxide levels were determined using lucigenin-enhanced chemiluminescence. Superoxide levels in situ were also examined using dihydroethidium (DHE) staining, and nitrotyrosine levels were examined using a nitrotyrosine antibody. Results: Endothelium-dependent vasorelaxation was significantly reduced in ritonavir-treated vessels compared to controls. There were significant increases in basal and NADPH-stimulated superoxide production in vessel rings treated with ritonavir compared to control vessels. Dihydroethidium staining and nitrotyrosine staining were also elevated in endothelial cells of ritonavir-treated vessels, indicating increased superoxide production and increased oxidative stress, respectively, in ritonavir-treated vessels compared to controls. Conclusions: These data demonstrate that HIV protease inhibitor ritonavir causes a significant reduction in endothelium-dependent vasorelaxation in cultured porcine carotid arteries. Increased oxidative stress may be a possible mechanism of HIV protease inhibitor ritonavir-induced endothelial dysfunction.

KEYWORDS HIV protease inhibitor ritonavir; Endothelium-dependent vasorelaxation; Porcine arteries

1 Current Address: Section of Leukocyte Biology, Department of Pediatrics, Baylor College of Medicine, Houston, TX 77030, USA.

Time for primary review 13 days


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Am. J. Pathol.Home page
X. Wang, H. Chai, P. H. Lin, Q. Yao, and C. Chen
Roles and Mechanisms of Human Immunodeficiency Virus Protease Inhibitor Ritonavir and Other Anti-Human Immunodeficiency Virus Drugs in Endothelial Dysfunction of Porcine Pulmonary Arteries and Human Pulmonary Artery Endothelial Cells
Am. J. Pathol., March 1, 2009; 174(3): 771 - 781.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
M. P. Dube, S. E. Lipshultz, C. J. Fichtenbaum, R. Greenberg, A. D. Schecter, S. D. Fisher, and for Working Group 3
Effects of HIV Infection and Antiretroviral Therapy on the Heart and Vasculature
Circulation, July 8, 2008; 118(2): e36 - e40.
[Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
X. Wang, H. Mu, H. Chai, D. Liao, Q. Yao, and C. Chen
Human Immunodeficiency Virus Protease Inhibitor Ritonavir Inhibits Cholesterol Efflux from Human Macrophage-Derived Foam Cells
Am. J. Pathol., July 1, 2007; 171(1): 304 - 314.
[Abstract] [Full Text] [PDF]

Home page
 J Antimicrob ChemotherHome page
J. J. R. Blanco, I. S. Garcia, J. G. Cerezo, J. M. P. S. de Rivera, P. M. Anaya, P. G. Raya, J. G. Garcia, J. R. A. Lopez, F. J. B. Hernandez, and J. J. V. Rodriguez
Endothelial function in HIV-infected patients with low or mild cardiovascular risk
J. Antimicrob. Chemother., July 1, 2006; 58(1): 133 - 139.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
R. E. White, G. Han, C. Dimitropoulou, S. Zhu, K. Miyake, D. Fulton, S. Dave, and S. A. Barman
Estrogen-induced contraction of coronary arteries is mediated by superoxide generated in vascular smooth muscle
Am J Physiol Heart Circ Physiol, October 1, 2005; 289(4): H1468 - H1475.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
H. Chai, W. Zhou, P. Lin, A. Lumsden, Q. Yao, and C. Chen
Ginsenosides block HIV protease inhibitor ritonavir-induced vascular dysfunction of porcine coronary arteries
Am J Physiol Heart Circ Physiol, June 1, 2005; 288(6): H2965 - H2971.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.